Genetically-stable engineered optogenetic gene switches modulate spatial cell morphogenesis in two- and three-dimensional tissue cultures Authors: Hannes M Beyer, Sant Kumar, Marius Nieke, Carroll M C Diehl, Kun Tang, Sara Shumka, Cha San Koh, Christian Fleck, Jamie A Davies, Mustafa Khammash, Matias D Zurbriggen Published: 2024 ABSTRACT AbstractRecent advances in tissue engineering have been remarkable, yet the precise control of cellular behavior in 2D and 3D cultures remains challenging. One approach to address this limitation is to genomically engineer optogenetic control of cellular processes into tissues using gene switches that can operate with only a few genomic copies. Here, we implement blue and red light-responsive gene switches to engineer genomically stable two- and three-dimensional mammalian tissue models. Notably, we achieve precise control of cell death and morphogen-directed patterning in 2D and 3D tissues by optogenetically regulating cell necroptosis and synthetic WNT3A signaling at high spatiotemporal resolution. This is accomplished using custom-built patterned LED systems, including digital mirrors and photomasks, as well as laser techniques. These advancements demonstrate the capability of precise spatiotemporal modulation in tissue engineering and open up new avenues for developing programmable 3D tissue and organ models, with significant implications for biomedical research and therapeutic applications.Subject terms: Genetic engineering, Optogenetics, Pattern formation, Synthetic biology, Hardware and infrastructure Introduction The field of tissue engineering constantly seeks innovation to recapitalize processes involved in the formation of in vivo tissues in in vitro environments. A plethora of methods has greatly advanced the field, which includes various tissue maintenance protocols, the development of extracellular matrices, and methods for the fabrication of tissues such as bioprinting. However, the external regulation of biological processes with spatiotemporal precision and patterned structures remains a persistent challenge1. Biological engineering efforts have greatly advanced our attempts to understand and design biology. Natural and engineered molecular switches enable the regulation of the physiological behavior of biological systems and constitute indispensable routine techniques in industry and fundamental life sciences alike2,3. Concepts inherent to synthetic biology brought about design strategies that rendered biology rational and predictive, thereby improving the accuracy with which one may control biology4,5. Molecular switches have been engineered to selectively respond to external stimuli ranging from small molecules, temperature, or pH, to optical stimulation6. The development of light-responsive molecular tools utilizing a wide variety of natural and engineered photoreceptors to precisely regulate diverse biological activities in orthogonal environments ushered in the field of “non-neuronal optogenetics”. In contrast to chemical inducers, light provides high spatial and temporal resolution, reversibility, and facilitates computer control of dynamic biological responses, e.g., by automated programming of light intensity profiles or patterned and pulsatile illumination regimes7. To date, optogenetics has found broad application in pro- and eukaryotic organisms, likewise in vitro and in vivo. Examples include the modulation of cell adhesion8,9, viral infectivity10,11, extracellular cell signaling12–14, sub-cellular protein localization and activity15–20, and the regulation of endogenous and synthetic promoters as well as gene editing21–30. Despite the ongoing development and increasing potential of three-dimensional tissue cultures in regenerative and personalized medicine, as well as their growing relevance as alternatives to animal testing, the widespread utilization of optogenetic regulation of biological processes within these cultures has remained largely untapped31. For example, the ever-increasing complexity and tissue resemblance of organoid models would greatly benefit from optogenetic modulation because compared to in vivo models, they are much more compatible with optogenetic intervention due to the controlled cultivation conditions and better light permeability of the specimen, as demonstrated recently32. As illustrated in this study, creating uniformly light-responsive engineered tissues for both 2D and 3D models requires the implementation of suitable genome engineering strategies. Optogenetic gene expression systems represent one of the most versatile control strategies known. Rather than individually engineering and optimizing distinct biological modules for optogenetic control, light-regulated promoters can direct the dynamic production of arbitrary bioactive molecules within cells. Despite the time delay resulting from RNA transcription and protein translation, gene switches often represent the easiest way of introducing optogenetic control into a given experimental setup. The use of photoreceptors responsive to distinct portions of the light spectrum also enabled optogenetic transcriptional control of multiple and individual genes, thus providing means to induce various cellular events in selected subsets of cells and reconstruct intertwined functional networks22,33,34. Optogenetic gene expression systems are imminently suitable for use in single cells or two-dimensional animal cell cultures, with some striking examples of technology transfer into whole animals16,24,29,35,36. Nevertheless, the majority of these applications depend on transiently introducing the required genes into a population of cultured cells or tissues through transfection or transduction. While this strategy suffices for proof-of-principle experiments, the associated mosaicity caused by a heterogeneous distribution of components and temporal system instability due to dilution and degradation effects, discourage the use of transient gene transfer when deriving sophisticated experimental models. For instance, light-guided cell patterning, control of cell viability and morphology, or signal propagation in 3D culture models all necessitate stable genomic integration of the optogenetic tools. Non-transfected, hence non-responsive cells interfere with the integrity of the systems and the spatial resolution. In this work, we developed an experimental strategy that integrates optogenetic tools, genomic engineering approaches, and spatially precise illumination technologies to derive 2D and 3D mammalian tissue cultures. For this, we first engineered and systematically characterized blue and red light-responsive optogenetic gene expression systems, generating genomically stable mammalian cell lines of various origins. Subsequently, we initiated cellular necroptosis in both 2D and 3D cultures using precise illumination techniques at scales down to micrometers. These techniques involved the utilization of photomasks, laser stimulation, as well as pattern-projection methods such as light sheets and digital-micromirror devices (DMD). Furthermore, we enabled spatial control of cell-cell communication via optogenetic control of WNT3A signaling, crucial for stem cell differentiation and tissue engineering. The resulting cell lines regulated morphogen signaling among three-dimensional spheroid cultures, acting as synthetic WNT3A organizer centers. The tools developed here will serve the future study of WNT3A signaling and necroptosis through optogenetic regulation of gene expression. Our findings offer insights into selecting appropriate optogenetic gene expression systems and their integration as essential elements within mammalian designer genomes. Additionally, they pave the way for largely untapped opportunities in optogenetic stem cell engineering and represent initial steps toward the eventual establishment of optogenetically programmable 3D tissue and organ models. Results Design of optogenetic gene switches To develop mammalian cell lines genomically equipped with optogenetic gene expression switches for controlling diverse cell behaviors, we first identified suitable gene switches that remain functional when expressed from a few genomic copies. Strategies to regulate gene expression in mammalian cell systems optogenetically have been devised using a variety of different photoreceptors with unique responses to light of different colors. Systems sensitive to UVB33, blue17,22,24,33,37–42, green25,34, and red/far-red21,28,34,43,44 light have allowed individual genes to be controlled using four main architectural principles: protein dimerization21,22,28,34,37,41, DNA binding24,25, protein localization16,17,42, and protein clustering25,39,43. We focused on variants of red/far-red and blue light-inducible gene expression systems that rely on the induction of protein heterodimerization. We concentrated here on systems we have developed or tested over the past years using transient transfection approaches and provide us with an easy-to-estimate quantitative output. In particular, we selected those for which we would expect either good dynamic induction ranges22, reversibility21, or low basal expression levels based on our experience (Fig. 1A, B). Additionally, we included a single-component blue light system relying on light-regulated modulation of DNA binding, because it has a simpler architecture and fewer required components (Fig. 1C). Design of optogenetic switches for genomic cell engineering. A–C Modes of function for the optogenetic gene switches. Light exposure activates the expression of a gene of interest (GOI) via recruitment of the transactivation domain VP16 to a minimal CMV promoter (Pmin). A RED gene switches utilize the PhyBN/PIF6APB interaction and either E or TetR as the DNA-binding domain specific for the etr8 or TCE DNA elements, respectively. Red light (R) activates PhyBN and initiates binding to PIF6APB, and thus recruitment of the reconstituted TF to the target sequence of the respective DNA-binding domain to the synthetic promoter, whereas far-red light causes dissociation. B BLUE gene switch implemented either on one (SINGLE) or two (DUAL) independent vectors. Blue light causes the binding of LOVpep to ePDZb via relaxation of helix Jα exposing the otherwise caged ePDZb-interacting peptide. C The EL222 single-component gene switch exhibits natural photo-regulated DNA binding capacity to the C120 operator sequence in response to blue light. Fusion of EL222 to VP16 results in a functional optogenetic TF for eukaryotic cells. D General architecture of transposition-competent vectors encoding photoswitches. E Architecture of attenuated (Ra, δ spacing, no ITRs), transposition-incompetent (R, no ITRs), and transposition-competent (Rt) reporter constructs utilizing SEAP as the GOI (see Table S1, Supplementary Information, for details). TCE contains seven tetO repeats. F Functional tests of tTA (TetR-VP16) and eTA (E-VP16)-activatable SEAP reporter constructs as in (E) using transient transfection together with the respective activators (Act) into CHO-K1 cells. p-values: tetO7-R, 1.622e−4; tetO7-Rt, 1.319e−4; etr8-R, 8.976e−5; etr8-Rt, 2.577e−3. G Transient transfection test of transposition-competent vectors for the REDTET and REDE system as in (D) for E and TetR-specific systems in CHO-K1 cells. The attenuated TetR-specific reporter construct contained 13 tetO operator repeats. p-values: tetO13-Ra, 2.332e-7; tetO7-R, 2.331e-7; tetO7-R, 6.052e-8; etr8-Ra, 1.203e-5; etr8-R, 7.520e-6; etr8-Rt, 1.922e-5. H Transient test of BLUESINGLE and BLUEDUAL transposition-competent vectors in CHO-K1 cells as in (D). p-values: Single-Ra, 1.514e-6; Single-R, 6.492e-8; Single-Rt, 4.344e-6; Dual-Ra, 1.027e-3; Dual-R, 6.120e-7; Dual-Rt, 3.229e-5. I Transient test of the transposition-competent vector encoding the EL222 photoswitch in CHO-K1 cells. p-value: 8.224e-7. F–I Used reporter constructs as in (E). Data represent mean values with one standard deviation of four biological replicates compared with two-sided independent Student’s t-tests. **, 1e-3